Oruka Therapeutics (ORKA) Interest Coverage Ratio Growth (1y) (2011 - 2020)
Powered by 
Analysis
Oruka Therapeutics (ORKA) Interest Coverage Ratio Growth (1y) (2011 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -176.09% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 93.04% |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -25.59% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,170.12% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -53.46% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 99.48% |
| 10 | Oruka Therapeutics | 5.85 Bn | 4.12 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 20.21% |
| Jun 30, 2020 | 13.13% |
| Mar 31, 2020 | 43.57% |
| Sep 30, 2019 | -50.06% |
| Jun 30, 2019 | 30.06% |
| Mar 31, 2019 | 35.77% |
| Sep 30, 2018 | 62.86% |
| Jun 30, 2018 | 74.14% |
| Mar 31, 2018 | 57.80% |
| Sep 30, 2015 | -23.28% |
| Jun 30, 2015 | 43.50% |
| Mar 31, 2015 | -14.81% |
| Jun 30, 2014 | -301.67% |
| Mar 31, 2014 | -123.36% |
| Jun 30, 2013 | -4.63% |
| Mar 31, 2013 | 23.90% |
| Sep 30, 2012 | -1.92% |
| Jun 30, 2012 | 32.81% |
| Mar 31, 2012 | -219.26% |
| Dec 31, 2011 | 117.37% |